Ukraine proposes $100 bln US weapons deal for security guarantees - FT
Investing.com - Pfizer reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Pfizer announced earnings per share of $1.07 on revenue of $18.98B. Analysts polled by Investing.com EPS of $0.9672 on revenue of $18.62B.
Pfizer 's are up 14% and is trading at $42.10 , still down 2.27% from its 52 week high of $43.08 set on Wednesday, December 9, 2020.
Pfizer follows other major Healthcare sector earnings this month
Pfizer's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar